1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Celtic Pharma Development Services: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tolerability Study of Xerecept® in Pediatric Patients XERECEPT - Brain Edema, Brain Tumor | Phase 1 / Phase 2 | Terminated | Celtic Pharma Development Services | 15 | 2010-06-01 | 2013-07-30 |
| Xerecept Intravenous Dose Escalation in Japanese and Caucasian Volunteers Xerecept 1.0, Xerecept 2.0, Xerecept 3.0 - Edema | Phase 1 | Completed | Celtic Pharma Development Services | 38 | 2008-12-01 | 2013-07-30 |
Edema (2) · Brain Edema (1) · Brain Neoplasms (1)
Corticotropin-Releasing Hormone (1)
United States (2)